Cancer metabolism is characterized by the deregulated uptake of amino acids that arises from a complex interplay between signaling pathways and transporters compared to adjacent normal tissue tumors showing high expression of several members of the amino acid transporters family, which is associated with tumor progression, clinical outcome, and treatment resistance. The gene discussed is SLC38A7; the disease is cancer.